Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Li Zhang
Sun Yat-sen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Second Hospital of Anhui Medical University
Hefei, Anhui, China
- Southern Medical University Affiliated Nanfang Hospital
Guangzhou, Guangdong, China
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
- Guangxi Medical University Affiliated Tumor Hospital
Nanning, Guangxi, China
- Baoding No.2 Central Hospital
Baoding, Hebei, China
- Henan Cancer Center
Zhengzhou, Henan, China
- Nantong Tumor Hospital
Nantong, Jiangsu, China
- Xuzhou Central Hospital
Xuzhou, Jiangsu, China
- Linyi Cancer Hospital
Linyi, Shandong, China
- Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
- Shanghai East Hospital
Shanghai, Shanghai Municipality, China
- Zhejiang Provincial People'S Hospital
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Nov 2021
- Primary completion
- 23 Feb 2023
- Completion
- 16 May 2024
- Last update posted
- 7 Aug 2024
- Registered enrollment
- 34
- Registry id
- NCT05068427
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.